Prevalence of nephrocalcinosis in children with congenital adrenal hyperplasia.

Congenital adrenal hyperplasia nephrocalcinosis prevalence

Journal

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences
ISSN: 1735-1995
Titre abrégé: J Res Med Sci
Pays: India
ID NLM: 101235599

Informations de publication

Date de publication:
2022
Historique:
received: 02 10 2021
revised: 20 01 2022
accepted: 26 01 2022
entrez: 28 3 2022
pubmed: 29 3 2022
medline: 29 3 2022
Statut: epublish

Résumé

We aimed to investigate the prevalence of nephrocalcinosis (NC) among children with diagnosed congenital adrenal hyperplasia (CAH). Our findings would be helpful for earlier diagnosis, management, and prevention of NC-related complications. In this cross-sectional study, children with CAH, aged <18 years old who were regularly referred for follow-up, were included. The information of the patients was extracted from their medical files, and they underwent renal ultrasonography for evaluation of the presence of NC. From 120 studied patients with CAH, four patients (3.3%) had NC. The prevalence of NC was higher in males than females ( The results of this study indicated a 3.3% prevalence rate of NC for children with CAH. NC had a trend to be more prevalent in male children with CAH. Though it was not significantly different but given that the mean age and age at diagnosis of CAH in children with CAH and NC was lower that CAH patients without NC, it is suggested that in patients with CAH and NC other factors such as genetic background or unknown disease related factors are associated with hypercalcemia and NC.

Sections du résumé

Background UNASSIGNED
We aimed to investigate the prevalence of nephrocalcinosis (NC) among children with diagnosed congenital adrenal hyperplasia (CAH). Our findings would be helpful for earlier diagnosis, management, and prevention of NC-related complications.
Materials and Methods UNASSIGNED
In this cross-sectional study, children with CAH, aged <18 years old who were regularly referred for follow-up, were included. The information of the patients was extracted from their medical files, and they underwent renal ultrasonography for evaluation of the presence of NC.
Results UNASSIGNED
From 120 studied patients with CAH, four patients (3.3%) had NC. The prevalence of NC was higher in males than females (
Conclusion UNASSIGNED
The results of this study indicated a 3.3% prevalence rate of NC for children with CAH. NC had a trend to be more prevalent in male children with CAH. Though it was not significantly different but given that the mean age and age at diagnosis of CAH in children with CAH and NC was lower that CAH patients without NC, it is suggested that in patients with CAH and NC other factors such as genetic background or unknown disease related factors are associated with hypercalcemia and NC.

Identifiants

pubmed: 35342446
doi: 10.4103/jrms.jrms_872_21
pii: JRMS-27-16
pmc: PMC8943593
doi:

Types de publication

Journal Article

Langues

eng

Pagination

16

Informations de copyright

Copyright: © 2022 Journal of Research in Medical Sciences.

Déclaration de conflit d'intérêts

There are no conflicts of interest.

Références

Pol J Radiol. 2015 Sep 05;80:417-24
pubmed: 26413177
Saudi J Kidney Dis Transpl. 2017 Sep-Oct;28(5):1064-1068
pubmed: 28937064
J Pediatr Adolesc Gynecol. 2017 Oct;30(5):520-534
pubmed: 28450075
Indian J Nephrol. 2017 Sep-Oct;27(5):410-411
pubmed: 28904442
Lancet. 2017 Nov 11;390(10108):2194-2210
pubmed: 28576284
Front Pediatr. 2018 Apr 12;6:98
pubmed: 29707529
J Clin Endocrinol Metab. 2018 Nov 1;103(11):4043-4088
pubmed: 30272171
J Endocr Soc. 2017 Aug 01;1(9):1160-1167
pubmed: 29264571
Pediatr Nephrol. 2010 Jan;25(1):49-59
pubmed: 21476230
World J Urol. 2005 Nov;23(5):302-3
pubmed: 16320059
Acta Biochim Pol. 2018;65(1):25-33
pubmed: 29543924
Turk J Pediatr. 2013 Jan-Feb;55(1):58-62
pubmed: 23692833
Nephron. 1994;68(4):507-8
pubmed: 7870238
Pol J Radiol. 2015 Aug 05;80:379-81
pubmed: 26309449
J Pediatr (Rio J). 2014 May-Jun;90(3):300-7
pubmed: 24560529
Am J Kidney Dis. 2004 Jul;44(1):e7-12
pubmed: 15211456
Curr Opin Pediatr. 2019 Aug;31(4):550-554
pubmed: 31295195
Horm Res Paediatr. 2011;76(2):73-85
pubmed: 21597280

Auteurs

Yahya Madihi (Y)

Metabolic Liver Disease Research Center, Department of Pediatric Nephrology, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Neda Mostofizadeh (N)

Metabolic Liver Disease Research Center, Isfahan Endocrine and Metabolism Research Center, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Hossein Shamsipour Dehkordi (H)

School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Maryam Riahinezhad (M)

Department of Radiology, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Silva Hovsepian (S)

Metabolic Liver Disease Research Center, Isfahan Endocrine and Metabolism Research Center, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Noushin Rostampour (N)

Metabolic Liver Disease Research Center, Isfahan Endocrine and Metabolism Research Center, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Elham Hashemi Dehkodi (EH)

Metabolic Liver Disease Research Center, Isfahan Endocrine and Metabolism Research Center, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Mahryar Mehrkash (M)

Department of Pediatric Nephrology, Imam Hossien Children's Hospital, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Tooba Momen (T)

Department of Allergy and Clinical Immunology, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Mahin Hashemipour (M)

Metabolic Liver Disease Research Center, Isfahan Endocrine and Metabolism Research Center, Imam Hossien Children's Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.

Classifications MeSH